Total planned funding: $589,553,949
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $120,870,323 |
Mozambique | $96,953,399 |
Zambia | $82,700,344 |
South Africa | $32,979,308 |
Kenya | $30,077,923 |
Vietnam | $25,957,622 |
Burundi | $18,526,474 |
Haiti | $18,424,595 |
India | $17,653,182 |
Tanzania | $16,684,842 |
Rwanda | $13,744,199 |
Côte d'Ivoire | $12,291,632 |
Indonesia | $12,291,188 |
Zimbabwe | $9,902,898 |
Cambodia | $7,275,000 |
Asia Regional Program | $7,127,614 |
Ghana | $6,982,500 |
Botswana | $6,460,003 |
Papua New Guinea | $6,195,286 |
Uganda | $5,807,847 |
South Sudan | $5,709,991 |
Democratic Republic of the Congo | $5,192,175 |
Caribbean Region | $5,044,985 |
Malawi | $5,037,205 |
Angola | $4,689,597 |
Ethiopia | $4,073,650 |
Eswatini | $2,962,089 |
Central America Region | $2,283,457 |
Dominican Republic | $1,668,747 |
China | $1,500,000 |
Namibia | $1,497,275 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Thailand | $278,599 |
Organizational Types
NGO | $581,883,949 |
Implementing Agency | $7,670,000 |
Program Areas
Care | $159,911,162 |
Treatment | $159,149,976 |
Prevention | $150,209,084 |
Governance and Systems | $60,279,624 |
Testing | $60,004,103 |
Budget Codes
HTXS: Treatment: Adult Treatment | $140,213,247 |
HVOP: Sexual Prevention: Other Sexual Prevention | $81,745,149 |
HKID: Care: Orphans and Vulnerable Children | $67,034,361 |
HBHC: Care: Adult Care and Support | $65,488,270 |
HVCT: Testing: HIV Testing and Counseling | $60,004,103 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $38,590,568 |
HLAB: Laboratory Infrastructure | $21,738,946 |
HVSI: Strategic Information | $21,687,908 |
OHSS: Health Systems Strengthening | $16,852,770 |
HVTB: Care: TB/HIV | $15,651,122 |
PDTX: Treatment: Pediatric Treatment | $15,513,445 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,086,517 |
PDCS: Care: Pediatric Care and Support | $11,737,409 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,598,927 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,928,810 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
HMIN: Biomedical Prevention: Injection Safety | $687,784 |
HMBL: Biomedical Prevention: Blood Safety | $571,329 |